In an adult with confirmed leptospirosis who develops severe pulmonary hemorrhage or refractory shock, should hydrocortisone be given, and what is the recommended dosing regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydrocortisone for Leptospirosis

In adults with confirmed leptospirosis and refractory septic shock requiring vasopressors, hydrocortisone should be given at 200 mg/day IV, following the same principles as septic shock management; however, for severe pulmonary hemorrhage without shock, the evidence is insufficient to recommend routine corticosteroid use, though it may be considered in life-threatening cases based on limited case reports.

Clinical Decision Algorithm

For Leptospirosis with Refractory Shock:

When to Give Hydrocortisone:

  • Patient has confirmed or suspected leptospirosis AND
  • Requires vasopressor support (norepinephrine, vasopressin, etc.) AND
  • Hemodynamic instability persists despite adequate fluid resuscitation

Do NOT give if:

  • Hemodynamic stability achieved with fluids and vasopressors alone 1
  • No shock present (sepsis without shock) 1

Dosing Regimen:

  • Hydrocortisone 200 mg/day IV 1
  • Administer as continuous infusion (preferred) 1 OR divided doses every 6 hours 2
  • If using infusion, give 50-100 mg bolus first 2
  • Continue until vasopressors no longer required, then taper 1

For Severe Pulmonary Hemorrhage:

The evidence here is highly uncertain and contradictory. A 2025 Cochrane review found very low-certainty evidence that corticosteroids may have little to no effect on mortality or serious adverse events in leptospirosis 3. A 2014 systematic review identified only one randomized trial showing corticosteroids were ineffective and potentially increased nosocomial infections 4.

However, recent case reports describe dramatic improvement with pulse methylprednisolone in severe pulmonary hemorrhagic syndrome 5, 6. A 2026 Australian ICU study showed excellent outcomes (100% survival) in 60 critically ill leptospirosis patients, but only 38% received corticosteroids—primarily short-course hydrocortisone for blood pressure support, not specifically for pulmonary hemorrhage 7.

Practical Approach for Pulmonary Hemorrhage:

  • If shock is present: Follow the refractory shock algorithm above
  • If no shock but life-threatening pulmonary hemorrhage: Consider pulse methylprednisolone 500-1000 mg/day for 3 days based on case report evidence 5, 6, recognizing this is not evidence-based but may be justified when mortality appears imminent
  • Monitor closely for secondary infections, hyperglycemia, and hypernatremia 2

Key Evidence Considerations

The Surviving Sepsis Campaign guidelines provide the framework here 1. These guidelines specifically state to avoid hydrocortisone if hemodynamic stability can be achieved with fluids and vasopressors alone. Only when this fails should hydrocortisone 200 mg/day be initiated (weak recommendation, low-quality evidence).

Critical distinction: The sepsis guidelines apply to leptospirosis-induced septic shock, but there is no high-quality evidence specifically supporting corticosteroids for leptospirosis pulmonary hemorrhage without shock. The Cochrane review explicitly concluded there is insufficient evidence to recommend corticosteroids for leptospirosis in general 3.

Monitoring and Tapering

  • Monitor: Blood glucose (treat hyperglycemia), sodium (watch for hypernatremia), potassium, and signs of secondary infection 8, 2
  • Taper: When vasopressors discontinued, gradually reduce hydrocortisone rather than abrupt cessation 1, 2
  • Watch for rebound: Monitor for recurrence of inflammation or adrenal insufficiency after stopping, especially if treatment exceeded 14 days 8

Common Pitfalls

  1. Giving corticosteroids too early: Do not use if hemodynamic stability achieved with standard resuscitation 1
  2. Using for sepsis without shock: Contraindicated 1
  3. Abrupt discontinuation: Always taper to avoid adrenal crisis 2
  4. Assuming pulmonary hemorrhage alone is an indication: The evidence for this is extremely weak and based only on case reports 5, 6
  5. Ignoring infection risk: The only RCT in leptospirosis showed increased nosocomial infections with corticosteroids 4

The Australian ICU experience demonstrates that excellent outcomes (100% survival) can be achieved with standard sepsis management principles without routine corticosteroid use 7, reinforcing that corticosteroids should be reserved for refractory shock only.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.